HOME | Career | Contact us
 
 
Corporate
 
 
Fact Sheet > Milestone
Zuventus is driven by a team of professionals with exceptional performance record in previous assignments. Naturally there was no dearth of courage to set challenging goals and achieving them through conviction and confidence. What followed was slew of milestones, perhaps even beyond imagination of most, if not all pharma players:
All India Launch with 400 field personnel (July, 2002).
Fastest to cross ORG-IMS reflections of 100 Cr., 200 Cr. and now even 600 Cr. mark.
Launch of speciality focused divisions for effective penetration in multiple specialities and market segments.
 
Gromaxx: 2005 – Gastroenterology & Respiratory
Oncocare: 2008 – Oncology
Odenea: 2010 – Pain Management
Generia & Institutions: 2012 – To tap vast potential of generics, hospitals and institutions
Building leader brands: (Source: ORG-IMS)
 
Augpen Maxtra
Eslo Feronia
Bevon Merotec
Zostum Netromax
Successful entry into exciting field of biotechnology – Enoxarin, Eporise, Peglast.
Joining hands with global giants and entry into the field of vaccines: Sanofi Pasteur – Verorab.
Partnership with MNCs for exciting cutting edge products
 
Have been marketing Gutclear containing Lactilol from Dupont (Danisco) with their technical support since past 4 years
Soon to be launched Dupont (Danisco) probiotic Restore II under Zuventus own brand name Florestore
Launching of ‘first time in India’ molecules with unique mode of action : Troxip (Troxipide), Lafaxid (Lafutidine), Seretra (Seretradrost).
Entry into hitec area of sprays and pumps through association with globally renowned Aptar Pharma – a German devices company.
Set up our own Manufacturing unit at Jammu which rolled out the first batch in the month of June’11
Our own Formulation R&D starting October’12.
Creating records and breaking them on a regular basis has almost become a habit with Zuventus. Needless to mention, many such milestones are quite on cards.
 
© 2013. All Rights Reserved. Zuventus HealthCare Ltd.